Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

The vague language of El Salvador's $1.4 billion deal with the IMF may imply that it might stop buying Bitcoin at some point, ...

Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...

"The initiative reflects our continuous efforts." Supermarket to roll out major change at 77 locations nationwide: 'We're excited for our customers' first appeared on The Cool Down.

The Anderson transition is a phase transition that occurs in disordered systems, which entails a shift from a diffusive state ...

Recently, the work was completed by the group of Prof. Sheng Meng from the Institute of Physics, Chinese Academy of Sciences, and Beijing National Research Center for Condensed Matter Physics. By ...

The FDA has expanded the labeling for Izervay (avacincaptad pegol) to include longer-term administration for geographic ...

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...

Research and development expenses were $12.6 million for the second quarter of fiscal 2025, compared with $12.0 million for the same period a year ago, with the increase primarily attributable to ...

Oleogel-S10 is an effective and well-tolerated long-term treatment for epidermolysis bullosa, including patients with severe forms of the disease.